Design of phase I and II clinical trials in cancer: a statistician's view.
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use* / Q000633:toxicity; D004341:Drug Evaluation; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D012107:Research Design; D012306:Risk; D013223:Statistics as Topic
D000970:Antineoplastic Agents